Why Read “The Gray Sheet”?
“The Gray Sheet” provides expert, in-depth analysis of the device and diagnostics industries in one single resource every week. For more than 30 years it has been the industry's most-trusted resource for one-stop news and regulatory coverage, featuring current and future FDA activities (including recalls and enforcement actions); insight into reimbursement issues and ever-changing policy at CMS; business developments; promotion and advertising updates; and constantly-updated news from Capitol Hill.
Who Reads “The Gray Sheet”?
Device and diagnostics CEOs and other C-suite executives, regulatory affairs staff, reimbursement specialists, in-house counsel, and clinical affairs staff plus consultants, lobbyists, and FDA officials and staff rely on “The Gray Sheet” to:
- Help them understand and prepare for changes in FDA and CMS policy
- Track the competition, from R&D and clinical trials to pre-market filings and product launches, and from sales and marketing strategies to quarterly earnings
- Improve business practices and deliver what venture capitalists want
Subscription Terms
Subscription Options
Buy Now
Includes:
Email newsletter with latest headlines, breaking news alerts, and access to “The Gray Sheet” — weekly, in-depth coverage of the medical device and diagnostic industries.
Multiple users/site features: Contact Deanna Flanick at +1-908-547-2141 or D.Flanick@Elsevier.com.